Brodie S J, Wilson W C, O'Hearn P M, Muthui D, Diem K, Pearson L D
Virology Division/Retrovirology Laboratory, University of Washington School of Medicine, Seattle, Washington 98144, USA.
J Virol. 1998 Jul;72(7):5599-609. doi: 10.1128/JVI.72.7.5599-5609.1998.
We investigated the effects of pharmacological and lentivirus-induced immunosuppression on bluetongue virus (BTV) pathogenesis as a mechanism for virus persistence and induction of clinical disease. Immunologically normal and immunosuppressed sheep were infected subcutaneously with BTV serotype 3 (BTV-3), a foreign isolate with unknown pathogenicity in North American livestock, and with North American serotype 11 (BTV-11). Erythrocyte-associated BTV RNA was detected earlier and at greater concentrations in sheep treated with immunosuppressive drugs. Similarly, viral RNA and infectious virus were detected in blood monocytes earlier and at higher frequency in immunosuppressed animals: as many as 1 in 970 monocytes revealed BTV RNA at peak viremia, compared to <1 in 10(5) monocytes from immunocompetent sheep. Animals infected with BTV-3 had a higher virus burden in monocytes and lesions of greater severity than those infected with BTV-11. BTV RNA was detected by in situ hybridization in vascular endothelial cells and cells of monocyte lineage, but only in tissues from immunocompromised animals, and was most abundant in animals infected with BTV-3. In contrast, reverse transcription-in situ PCR showed BTV RNA from both viral serotypes in high numbers of tissue leukocytes and vascular endothelial cells from both immunosuppressed and, to a lesser extent, immunocompetent animals. Collectively, these findings show that BTV infection is widely distributed during acute infection but replication is highly restricted in animals with normal immunity. These findings also suggest that in addition to virulence factors that define viral serotypes, immunosuppression could play a role in the natural history of orbivirus infection, allowing for higher virus burden, increased virus persistence, and greater potential for acquisition of virus by the arthropod vector.
我们研究了药物诱导和慢病毒诱导的免疫抑制对蓝舌病毒(BTV)发病机制的影响,以此作为病毒持续存在和引发临床疾病的一种机制。免疫功能正常和免疫抑制的绵羊经皮下接种BTV血清型3(BTV-3,一种在北美家畜中致病性未知的外来毒株)以及北美血清型11(BTV-11)。在用免疫抑制药物治疗的绵羊中,红细胞相关的BTV RNA被更早、更高浓度地检测到。同样,在免疫抑制动物的血液单核细胞中,病毒RNA和传染性病毒被更早、更频繁地检测到:在病毒血症高峰期,每970个单核细胞中就有多达1个显示出BTV RNA,而免疫功能正常的绵羊每10⁵个单核细胞中检测到的BTV RNA小于1个。感染BTV-3的动物单核细胞中的病毒载量更高,病变也比感染BTV-11的动物更严重。通过原位杂交在血管内皮细胞和单核细胞系细胞中检测到BTV RNA,但仅在免疫受损动物的组织中检测到,并且在感染BTV-3的动物中最为丰富。相比之下,逆转录原位PCR显示,在免疫抑制动物以及在较小程度上免疫功能正常的动物的大量组织白细胞和血管内皮细胞中,两种病毒血清型的BTV RNA均有存在。总体而言,这些发现表明,BTV感染在急性感染期间广泛分布,但在免疫正常的动物中复制受到高度限制。这些发现还表明,除了定义病毒血清型的毒力因子外,免疫抑制可能在环状病毒感染的自然病程中发挥作用,导致更高的病毒载量、增加病毒持续存在以及节肢动物媒介获取病毒的更大可能性。